What is new for monoamine neurotransmitter disorders?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  2014-04-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10545-014-9697-4PMID 24696406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood

  2014cited by this paper
• Homovanillic acid in cerebrospinal fluid of 1388 children with neurological disorders

  2013cited by this paper
• Transdermal rotigotine in the treatment of aromatic L‐amino acid decarboxylase deficiency

  2013cited by this paper
• Brain dopamine-serotonin vesicular transport disease and its treatment.

  2013cited by this paper
• Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects

  2013cited by this paper
• Risk factors for cerebral palsy: current knowledge and future causal inference

  2013cited by this paper
• What is the role of dopamine in childhood neurological disorders?

  2013cited by this paper
• Levodopa‐induced dyskinesias in tyrosine hydroxylase deficiency

  2013influential reference
• Very early pattern of movement disorders in sepiapterin reductase deficiency

  2013cited by this paper
• Myoclonus

  2013cited by this paper
• Gene Therapy for Aromatic l-Amino Acid Decarboxylase Deficiency

  2012cited by this paper
• A homozygous frameshift mutation of sepiapterin reductase gene causing parkinsonism with onset in childhood.

  2012cited by this paper
• Tyrosine hydroxylase deficiency in Taiwanese infants.

  2012cited by this paper
• Sepiapterin reductase deficiency: A Treatable Mimic of Cerebral Palsy

  2012cited by this paper
• Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency

  2012cited by this paper
• The monoamine neurotransmitter disorders: an expanding range of neurological syndromes.

  2011cited by this paper
• "Stiff neonate" with mitochondrial DNA depletion and secondary neurotransmitter defects.

  2011cited by this paper
• Infantile parkinsonism-dystonia due to dopamine transporter gene mutations: another genetic twist.

  2011cited by this paper
• Expanding Phenotype and Clinical Analysis of Tyrosine Hydroxylase Deficiency

  2011cited by this paper
• Pseudoexon exclusion by antisense therapy in 6‐pyruvoyl‐tetrahydropterin synthase deficiency

  2011cited by this paper
• Bilateral subthalamic nucleus deep brain stimulation for dopa-responsive dystonia in a 6-year-old child.

  2011influential reference
• Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency

  2010cited by this paper
• Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study

  2010cited by this paper
• Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.

  2010cited by this paper
• Cerebrospinal fluid alterations of the serotonin product, 5-hydroxyindolacetic acid, in neurological disorders

  2010cited by this paper
• Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

  2009cited by this paper
• Movement disorders in children: Recent advances in management

  2009cited by this paper
• A new perspective on the treatment of aromatic L-amino acid decarboxylase deficiency.

  2009cited by this paper
• Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia.

  2009cited by this paper
• Infantile parkinsonism-dystonia: a dopamine "transportopathy".

  2009cited by this paper
• Aromatic L-amino acid decarboxylase deficiency in Taiwan.

  2009cited by this paper
• Two Greek siblings with sepiapterin reductase deficiency.

  2008cited by this paper
• Results from a phase I safety trial of hAADC gene therapy for Parkinson disease

  2008cited by this paper
• Mitochondrial diseases mimicking neurotransmitter defects.

  2008cited by this paper
• Unusually mild phenotype of AADC deficiency in 2 siblings.

  2007cited by this paper
• Tyrosine Hydroxylase Deficiency Presenting with a Biphasic Clinical Course

  2007cited by this paper
• Dopa-responsive hypersomnia and mixed movement disorder due to sepiapterin reductase deficiency

  2006cited by this paper
• Tyrosine Hydroxylase Deficiency

  2006cited by this paper
• Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder.

  2005cited by this paper
• Aromatic l-amino acid decarboxylase deficiency

  2004cited by this paper
• Levodopa‐responsive aromatic L–amino acid decarboxylase deficiency

  2004cited by this paper
• Detection of sepiapterin in CSF of patients with sepiapterin reductase deficiency.

  2002cited by this paper
• Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia.

  2001cited by this paper
• Aromatic L‐amino acid decarboxylase deficiency

  1992cited by this paper
• Clinical Chemistry 47:3 477–485 (2001) Molecular Diagnostics and Genetics Diagnosis of Dopa-responsive Dystonia and Other Tetrahydrobiopterin Disorders by the Study of Biopterin Metabolism in Fibroblasts

  year unknowncited by this paper

• A comparative exploration of monoamine neurotransmitter transport disorders: mechanisms, clinical manifestations, and therapeutic approaches

  2025influential citation
• Parkinsonism‐dystonia‐2: Case‐series study from Saudi Arabia

  2024cites this paper
• Common Transition Metal Oxide Nanomaterials in Electrochemical Sensors for the Diagnosis of Monoamine Neurotransmitter‐related Disorders

  2024cites this paper
• Advancements in Brain Research: The In Vivo/In Vitro Electrochemical Detection of Neurochemicals

  2024cites this paper
• Simultaneous assay of urine sepiapterin and creatinine in patients with sepiapterin reductase deficiency.

  2022cites this paper
• Quantification of monoamine biomarkers in cerebrospinal fluid: comparison of a UHPLC-MS/MS method to a UHPLC coupled to fluorescence detection method.

  2022cites this paper
• Real-Time Monitoring of Neurotransmitters in the Brain of Living Animals.

  2022cites this paper
• A case report of infantile parkinsonism-dystonia-2 caused by homozygous mutation in the SLC18A2 gene

  2021cites this paper
• Secondary biogenic amine deficiencies: genetic etiology, therapeutic interventions, and clinical effects

  2021cites this paper
• Inherited Neurotransmitter Disorders

  2020cites this paper
• Development and applications of novel strategies for the enhanced mass spectrometric quantification of biogenic amines

  2020cites this paper
• Neuroprotective Effects of OMO within the Hippocampus and Cortex in a D-Galactose and Aβ25–35-Induced Rat Model of Alzheimer's Disease

  2020cites this paper
• Cerebrospinal fluid monoamines, pterins, and folate in patients with mitochondrial diseases: systematic review and hospital experience

  2018cites this paper
• Diagnostic approach to neurotransmitter monoamine disorders: experience from clinical, biochemical, and genetic profiles

  2018cites this paper
• The Twists of Pediatric Dystonia: Phenomenology, Classification, and Genetics.

  2018cites this paper
• Comprehensive characterization of neurochemicals in three zebrafish chemical models of human acute organophosphorus poisoning using liquid chromatography-tandem mass spectrometry

  2018cites this paper
• Development, validation and comparison of surrogate matrix and surrogate analyte approaches with UHPLC-MS/MS to simultaneously quantify dopamine, serotonin and γ-aminobutyric acid in four rat brain regions.

  2018cites this paper
• Synaptic metabolism: a new approach to inborn errors of neurotransmission

  2018cites this paper
• Setting the stage for a role of the postsynaptic proteome in inherited neurometabolic disorders

  2018cites this paper
• L-menthol exhibits antidepressive-like effects mediated by the modification of 5-HTergic, GABAergic and DAergic systems

  2018cites this paper
• Red or Blue? Gold Nanoparticles in Colorimetric Sensing

  2018cites this paper
• Introductory Chapter: Basic Concept of Gold Nanoparticles

  2018cites this paper
• Expert to Expert: Paediatric Movement Disorders Pre-course Reading Bristol 18-19 October 2018

  2018cites this paper
• 44 – Neurotransmitter-Related Disorders

  2017cites this paper
• Biomarkers for the study of catecholamine and serotonin genetic diseases

  2017cites this paper
• An Indian family with tyrosine hydroxylase deficiency

  2017cites this paper
• Secondary Abnormal CSF Neurotransmitter Metabolite Profiles in a Pediatric Tertiary Care Centre

  2017cites this paper
• Phosphorylation mechanisms in dopamine transporter regulation.

  2017cites this paper
• Simultaneous measurement of monoamine metabolites and 5-methyltetrahydrofolate in the cerebrospinal fluid of children.

  2017cites this paper
• Inherited Metabolic Disorders with Associated Movement Abnormalities

  2016cites this paper
• Brain dopamine-serotonin vesicular transport disease presenting as a severe infantile hypotonic parkinsonian disorder

  2016cites this paper
• Simultaneous determination of eleven compounds related to metabolism of bioamines in rat cortex and hippocampus by HPLC-ECD with boron-doped diamond working electrode.

  2016cites this paper
• Dopamine depleters in the treatment of hyperkinetic movement disorders

  2016cites this paper
• Simultaneous Determination of the Neurotransmitters and Free Amino Acids in Rat Organs by LC-MS Analysis

  2016cites this paper
• Hereditary Dopamine Transporter Deficiency Syndrome: Challenges in Diagnosis and Treatment

  2016cites this paper
• Mise au point du dosage sanguin des métabolites de la voie du tryptophane en HPLC-MS/MS et perspectives dans le suivi biologique des patients atteints de phénylcétonurie

  2016cites this paper
• A Preliminary Study of DBH (Encoding Dopamine Beta-Hydroxylase) Genetic Variation and Neural Correlates of Emotional and Motivational Processing in Individuals With and Without Pathological Gambling

  2016cites this paper
• ADCY5-related dyskinesia: Broader spectrum and genotype–phenotype correlations

  2015cites this paper
• Genetics of Atypical Parkinsonism

  2015cites this paper
• Erbliche Stoffwechselkrankheiten – eine Übersicht

  2015cites this paper
• Monoamine neurotransmitter disorders—clinical advances and future perspectives

  2015cites this paper
• Mechanistic and Structural Analysis of Drosophila melanogaster Arylalkylamine N-Acetyltransferases

  2014cites this paper